Ridgecrest Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Ridgecrest Wealth Partners's PFE Position: Q1 2026 in Review
Ridgecrest Wealth Partners reduced its Pfizer (PFE) stake by 2% in Q1 2026, selling an estimated $13.6K and leaving 24,738 shares worth $695K. The position accounts for 0.38% of the portfolio, ranked #49.
Ridgecrest Wealth Partners first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.14M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Ridgecrest Wealth Partners held 24,738 shares of Pfizer worth $695K as of Q1 2026.
- Ridgecrest Wealth Partners sold 509 Pfizer shares in Q1 2026, an estimated $13.6K.
- Pfizer made up 0.38% of Ridgecrest Wealth Partners's portfolio in Q1 2026, its #49 holding.
- Ridgecrest Wealth Partners first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
- Ridgecrest Wealth Partners's Pfizer position peaked at $4.14M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Ridgecrest Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.